US Patent Issued to NICOX, FERA PHARMACEUTICALS on June 2 for "Method for treating vaso occlusive crises associated with Sickle cell disease" (American, French Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,783, issued on June 2, was assigned to NICOX SA (Sophia Antipolis, France) and FERA PHARMACEUTICALS LLC (Locust Valley, N.Y.).

"Method for treating vaso occlusive crises associated with Sickle cell disease" was invented by Brigitte Duquesroix-Chakroun (Cagnes sur Mer, France), Frank J. Dellafera (Locust Valley, N.Y.) and Scott Florentino (Locust Valley, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a treatment of vaso-occlusive crisis (VOC) associated with Sickle cell disease by administering a therapeutically effective amount of 4-(nitrooxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate."

The patent was filed ...